Solvay Amendment for Study Coordinator: Open-Label, 12-Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects

Grants and Contracts Details

StatusFinished
Effective start/end date4/6/109/30/13

Funding

  • Quintiles Inc: $150,980.00